Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.
Marisa P McGinleyPhilip A ColaRobert J FoxJeffrey A CohenJohn J CorboyDeborah M MillerPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2019)
Most individuals with MS report being unlikely to consider stopping MS therapy if their disease was considered "non-active." As the results of studies concerning DMT discontinuation are obtained, information from providers will be an important part of individuals' decision-making process.